Free Trial

Agilon Health (NYSE:AGL) Posts Earnings Results, Misses Estimates By $0.14 EPS

Agilon Health logo with Medical background

Key Points

  • Agilon Health reported a quarterly loss of ($0.25) EPS, significantly missing the consensus estimate of ($0.11).
  • The company's stock is currently trading at $1.82, with a market capitalization of approximately $751.32 million.
  • Analysts have mixed ratings on Agilon Health, with an average price target of $4.71 and varying recommendations from "buy" to "sell."
  • Want stock alerts on Agilon Health? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Agilon Health (NYSE:AGL - Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.25) EPS for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.14), Zacks reports. The firm had revenue of $1.39 billion for the quarter, compared to analyst estimates of $1.47 billion. Agilon Health had a negative return on equity of 63.31% and a negative net margin of 5.35%. The company's quarterly revenue was down 5.9% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.07) earnings per share.

Agilon Health Price Performance

NYSE:AGL traded up $0.02 during mid-day trading on Wednesday, reaching $0.90. The stock had a trading volume of 43,659,961 shares, compared to its average volume of 6,403,229. The company has a market capitalization of $372.97 million, a price-to-earnings ratio of -1.18 and a beta of 0.14. Agilon Health has a 1-year low of $0.71 and a 1-year high of $6.30. The stock's 50 day simple moving average is $2.16 and its two-hundred day simple moving average is $3.20.

Hedge Funds Weigh In On Agilon Health

Hedge funds have recently bought and sold shares of the company. Goldman Sachs Group Inc. lifted its holdings in Agilon Health by 6.6% in the first quarter. Goldman Sachs Group Inc. now owns 5,060,333 shares of the company's stock worth $21,911,000 after acquiring an additional 311,158 shares during the last quarter. AQR Capital Management LLC raised its holdings in shares of Agilon Health by 243.3% during the first quarter. AQR Capital Management LLC now owns 501,440 shares of the company's stock valued at $2,171,000 after buying an additional 355,365 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Agilon Health by 3.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,200 shares of the company's stock valued at $927,000 after buying an additional 7,209 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd raised its holdings in shares of Agilon Health by 28.4% during the first quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company's stock valued at $204,000 after buying an additional 10,424 shares during the last quarter.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. Evercore ISI lowered their price target on Agilon Health from $5.00 to $3.00 and set an "in-line" rating for the company in a report on Wednesday, July 9th. Citigroup upgraded Agilon Health from a "neutral" rating to a "buy" rating and increased their price target for the company from $3.25 to $5.00 in a report on Friday, April 25th. The Goldman Sachs Group increased their price target on Agilon Health from $2.50 to $5.00 and gave the company a "neutral" rating in a report on Thursday, May 8th. Cowen reiterated a "hold" rating on shares of Agilon Health in a report on Tuesday, April 15th. Finally, Sanford C. Bernstein upgraded Agilon Health from a "market perform" rating to an "outperform" rating and increased their price target for the company from $3.30 to $8.50 in a report on Tuesday, April 8th. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $4.07.

Check Out Our Latest Stock Analysis on Agilon Health

About Agilon Health

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

See Also

Earnings History for Agilon Health (NYSE:AGL)

Should You Invest $1,000 in Agilon Health Right Now?

Before you consider Agilon Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.

While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines